Skip to main content
SpringerLink
Log in

Schubförmige Multiple Sklerose

Therapieumstellung steigert Behandlungszufriedenheit der Patienten

  • infopharm
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  • Pressekonferenz „Die MS-Therapie mit Teriflunomid — individuell statt pauschal“, Berlin, 9. 5. 2018; Veranstalter: Sanofi Genzyme

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Matthias Herrmann (freier Medizinjournalist)

Authors
  1. Matthias Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herrmann, M. Therapieumstellung steigert Behandlungszufriedenheit der Patienten. InFo Neurologie 20, 40–41 (2018). https://doi.org/10.1007/s15005-018-2688-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-018-2688-5

Search

Navigation